Statins induce calcium-dependent mitochondrial permeability transition
- 1 February 2006
- journal article
- Published by Elsevier BV in Toxicology
- Vol. 219 (1-3), 124-132
- https://doi.org/10.1016/j.tox.2005.11.007
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Oxidation Injury in Patients Receiving HMG-CoA Reductase InhibitorsDrug Safety, 2002
- Role of tyrosine phosphorylation of phospholipase C γ1 in the signaling pathway of HMG‐CoA reductase inhibitor‐induced cell death of L6 myoblastsFEBS Letters, 1999
- Mitochondria and programmed cell death: back to the futureFEBS Letters, 1996
- The mitochondrial permeability transitionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Cytosolic Ca2+ Increase and Cell Damage in L6 Rat Myoblasts by HMG-CoA Reductase InhibitorsBiochemical and Biophysical Research Communications, 1994
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.JCI Insight, 1993
- Effect of a long-term treatment with lovastatin or fenofibrate on hepatic and cardiac ubiquinone levels in cardiomyopathic hamsterBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled StudyThe Journal of Clinical Pharmacology, 1993
- Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady stateThe Journal of Membrane Biology, 1979
- Safranine as a probe of the mitochondrial membrane potentialFEBS Letters, 1976